178 (PB058) - Characterizing mechanisms of resistance to BRAF and MEK inhibitors in cancers with Class 2 BRAF mutations: uncovering novel therapeutic opportunities
- Resource Type
- Abstract
- Source
- In
European Journal of Cancer October 2022 174 Supplement 1:S63-S64 - Subject
- Language
- ISSN
- 0959-8049